Topics
Latest
AI
Amazon
Image Credits:Getty Images
Apps
Biotech & Health
Climate
Image Credits:Getty Images
Cloud Computing
mercantilism
Crypto
endeavour
EVs
Fintech
Fundraising
Gadgets
Gaming
Government & Policy
Hardware
layoff
Media & Entertainment
Meta
Microsoft
Privacy
Robotics
Security
societal
Space
Startups
TikTok
Transportation
Venture
More from TechCrunch
Events
Startup Battlefield
StrictlyVC
newssheet
Podcasts
television
Partner Content
TechCrunch Brand Studio
Crunchboard
Contact Us
People with continuing kidney disease or those at risk of nerve failure are greatly strike by potassium imbalances in the body . These can even be life - threatening . While wearable glucose monitor lizard are now commonplace and have translate the life of diabetes patients , potassium monitoring is in its early childhood , as it ’s hard to do . Now startup are emerging to address the problem .
Proton Intelligenceis a Canada - based startup make grow a uninterrupted K monitoring product . It has now shut a $ 6.95 million seminal fluid round led by SOSV . Clinical tryout are afoot for the product , which is due to launch in 2025 .
Proton is developing a small gadget that would be inserted just below the skin for monitor atomic number 19 levels . This would connect with a smartphone app so that patient can monitor their potassium levels and get notice if their level move out of a secure range , base on modus vivendi choice like dieting or medication .
A clinician dashboard will provide a view of a patient ’s K trends , and forethought squad will be able to use the data to hunky-dory - tune therapy .
The party was co - founded by CEOSahan Ranamukhaarachchi(based in Vancouver , Canada ) and CSO Victor Cadarso ( based in Melbourne ) .
The two establish the startup after working on wearable biosensors as researchers in Switzerland 10 years ago . Ranamukhaarachchi went on to found a skin - based drug delivery inauguration ( Microdermics ) , while Cadarso became a professor in micro- and nano - sensors at Monash University in Melbourne . Proton has a commercial-grade - focussed HQ in Canada and a wholly owned R&D - pore subsidiary in Melbourne , Australia .
Ranamukhaarachchi evidence TechCrunch the squad did over 100 in - depth interviews with care teams to research their production . “ These highlight the devastating consequences of ‘ flying blind ’ when managing potassium levels , because delays in monitoring often lead to preventable hospitalizations , stopping therapy , or even sudden cardiac death , ” he said .
Join us at TechCrunch Sessions: AI
Exhibit at TechCrunch Sessions: AI
He described how patients talked about “ a constant fear of K imbalances , question if eat on a unmarried banana or lack a pedigree examination ” could move their health or even put their life at risk .
The problem is real . Some 10 % of the universe worldwideis affectedby chronic kidney disease , and thousands pass away each year because they do not have entree to affordable treatment .
Proton competes with a number of other emerge firms in the sphere .
AliveCorestimates potassium storey indirectly by find cardiac activeness ( it ’s bring up $ 154.3 million to date).Aliodoes potassium monitoring in dialysis patients ( it has raised $ 46 million).Renalyseout of Spain appraise K via finger - prick blood samples ( it has kick upstairs € 1 million ) . There are , of course of instruction , several others .
That enjoin , Proton ’s beginner arrogate that its solution will be more scalable : “ No other engineering science presently proffer this level of usability , accuracy , and clinical impact , ” state Ranamukhaarachchi .
In a argument , Mohan S. Iyer , general partner at SOSV , say : “ We are gallant to be the first institutional investor in Proton Intelligence … and we are worked up to continue to support them as they move into clinical validation . ”
The seed round also see involvement from We Venture Capital , Tenmile , LongeVC , 15th Rock , Exor , and Trampoline Venture Partners .
